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Abstract
Background: Evidence about the consequence of hyperemesis gravidarum (HG) on pregnancy outcomes is still
inconclusive. In this study, we evaluated if occurrence of hyperemesis gravidarum is associated with placental
dysfunction disorders and neonatal outcomes.
Methods: A prospective cohort study was conducted in a maternal and child health primary care referral center,
Budi Kemuliaan Hospital and its branch, in Jakarta, Indonesia. 2252 pregnant women visiting the hospital for regular
antenatal care visits from July 2012 until October 2014 were included at their first clinic visit. For women without,
with mild and with severe hyperemesis, placental dysfunction disorders (gestational hypertension, preeclampsia (PE)
, stillbirth, miscarriage), neonatal outcomes (birth weight, small for gestational age (SGA), low birth weight (LBW),
Apgar score at 5 min, gestational age at delivery) and placental outcomes (placental weight and placental-weight-
to-birth-weight ratio (PW/BW ratio)) were studied.
Results: Compared to newborns of women without hyperemesis, newborns of women with severe hyperemesis
had a 172 g lower birth weight in adjusted analysis (95%CI -333.26; -10.18; p = 0.04). There were no statistically
significant effects on placental dysfunction disorders or other neonatal outcome measures.
Conclusions: The results of our study suggest that hyperemesis gravidarum does not seem to induce placental
dysfunction disorders, but does, if severe lead to lower birth weight.
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Background
Nausea and vomiting are common and usually benign
symptoms of primarily the first trimester of pregnancy.
The onset of nausea correlates with the level of human
chorionic gonadotropin (hCG), which typically rises
within 4 weeks after the last menstrual period, peaking
at approximately 9 weeks of gestation [1]. Sixty percent
of nausea cases resolve by the end of the first trimester
and 91% by 20 weeks of gestation [1]. Hyperemesis
gravidarum is at the severe end of the nausea spectrum
and according to The International Statistical Classifica-
tion of Disease and Related Health Problems (ICD-9), is
defined as ‘persistent and excessive vomiting starting
before the end of the 22nd week of gestation’. Hyperemesis
gravidarum is clinically classified as mild or severe, depend-
ing on associated metabolic disturbances such as carbohy-
drate depletion, dehydration and electrolyte imbalance. Its
incidence is estimated at 0.3 to 1.5% of all live births but is
unevenly distributed on a global level [2–6]. Asian women,
for instance are more likely to suffer from hyperemesis than
Caucasian women [3, 5]. Hyperemesis greatly affects
maternal well-being and quality of life [7, 8] and is
among the most common reasons for pregnancy-
associated hospitalization [6, 9, 10].
Relatively little is known about the etiology of hyper-
emesis [6]. Causal roles of sex hormones, thyroid hor-
mones, H. pylori infections and paternal genes have
been suggested, although consensus has not been
reached [6, 11]. Levels of hCG are positively associated
with occurrence and severity of hyperemesis complaints,
as seen in multiple- or molar pregnancies [12, 13]. While
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benign nausea and vomiting in early pregnancy are
closely related to temporarily increased hCG levels, it
has been argued that in women with hyperemesis, the
persistently high hCG level dysregulates normal stimula-
tion of trophoblast migration, which consequently alters
placentation [14–16]. Ultimately abnormal placentation
could lead to placental dysfunction that clinically mani-
fests as gestational hypertension, preeclampsia, as well
as miscarriage, stillbirth and intra-uterine growth restric-
tion (IUGR) [15, 17–19]. In particular, elevated hCG
plasma levels in the second trimester are associated with
development of these conditions [13, 20]. Thus,
hyperemesis gravidarum, occurring in first and early
second trimester, could be an early pregnancy indica-
tor of a process that results in symptomatic placental
dysfunction later.
There is limited evidence about the consequences of
hyperemesis on maternal and offspring’s health. Two
large cohort studies in Scandinavian countries showed
that hyperemesis was associated with higher risk of
preeclampsia, lower birth weight and shorter gestational
duration [15, 21]. This was supported by several studies
suggesting higher risks of low birth weight (LBW), small
for gestational age (SGA), and preterm birth if mothers
experienced hyperemesis [22–24]. However, another
large study [25] and several smaller studies, [26, 27] did
not show such associations.
Women who experience severe hyperemesis have a
significantly reduced maternal caloric ‘intake’ and lose
additional nutrients and electrolytes [28]. This state
resembles fasting and often involves ketonuria, which is
frequently tested by clinicians in women suspected of
having hyperemesis [29, 30]. Previous studies have
shown that placental efficiency changes in women
exposed to famine. Increased placental weight in women
who were pregnant during the Dutch Hungerwinter sug-
gests that compensatory growth of the placenta can
occur in situations where nutritional resources are lack-
ing [31, 32]. The same compensation might occur in
women who experience severe hyperemesis gravidarum,
however evidence is lacking.
Both hyperemesis and placental dysfunction constitute
substantial maternal and neonatal health threats, par-
ticularly in the low and middle income countries where
health care resources are limited [33]. Therefore, further
exploration of a relation between hyperemesis and such
disorders is warranted.
Methods
The present study aimed to investigate the relation be-
tween hyperemesis and placental dysfunction disorders
(gestational hypertension, preeclampsia, miscarriage,
and stillbirth), and neonatal outcomes, including birth
weight, small for gestational age (SGA), Apgar score
and gestational age at delivery.
Study population
We used a prospective cohort of 2252 pregnant women
in the private mother-child health Budi Kemuliaan
Hospital and its branch (Budi Kemuliaan Petojo) in
Jakarta, Indonesia. The hospital provides secondary care
on maternal health, while its branch focuses on primary
care services. Women who were recruited were, there-
fore, representative of the pregnant women population
in an urban setting of a developing country. Pregnant
women were recruited during their first regular visit for
antenatal care (ANC) between July 2012 and October
2014. All women who attended clinic visits were invited
and asked to sign written informed consent. Participants
were examined and interviewed by midwives according
to standard clinical care and followed up until delivery.
After enrolment, information regarding personal
affairs, medical status and clinical information was
obtained through interviews by midwives at ANC visits.
This included socio-economic background of women
and partners, women’s medical history (including previ-
ous surgery, medication), current pregnancy (last men-
strual period (LMP), pre-pregnancy weight), obstetrical
history (parity, previous morbidity during pregnancy,
previous mode(s) of delivery), and family history of
disease. Clinical information at each ANC visit
included weight of the mother, blood pressure,
temperature, occurrence of hyperemesis gravidarum,
and presence of proteinuria.
Hyperemesis gravidarum exposure measurement
Hyperemesis gravidarum was diagnosed by midwives
during routine ANC visits. Details about duration of
complaints, weight loss, metabolic disturbances and
associated hospitalization were recorded. For analysis,
women were classified as those without, with mild or
with severe hyperemesis gravidarum (women with >5%
weight loss compared to pre-pregnancy weight). Only
women with hyperemesis diagnosed in the first or
second trimester were included [34].
Outcome measurements
Hypertensive disorders of pregnancy were classified by
International Society for the study of Hypertension in
Pregnancy (ISSHP) definitions [35]. Gestational hyper-
tension was defined as systolic blood pressure of 140
mmHg or more and/or diastolic blood pressure of 90
mmHg or more at two occasions in a woman with no
hypertension prior to 20 weeks of gestation. In women
with gestational hypertension, proteinuria was defined as
2+ dipstick in random urine samples. Preeclampsia was
diagnosed if women with gestational hypertension had
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proteinuria [36] or if there were also one or more con-
vulsions (eclampsia) [37]. Due to the low incidence of
eclampsia, we analyzed eclampsia patients combined
with the preeclampsia group. Chronic hypertension was
defined as blood pressure exceeding 140/90 mmHg
before pregnancy or before 20 weeks gestation, [38] and
only when found elevated at ≥ 2 occasions. Women who
were diagnosed with gestational hypertension or pre-
eclampsia received treatment according to the standard
hospital protocols.
Miscarriage was defined as fetal loss before 23 weeks
of pregnancy and/or weighing up to 500 g, and stillbirth
as birth of a baby with no signs of life at or after 28
weeks of gestation [39]. Small for Gestational Age (SGA)
was defined as birth weight at a particular gestational
age was below the 10th percentile of United States
National Reference for Fetal Growth [40]. Low Birth
Weight (LBW) was a birth weight below 2500 g [41].
Apgar scores were measured at 1, 5, and 10 min after
birth [42]. Reported outcome for Apgar score was the
score 5 min postpartum. Prematurity was defined as
birth before 37 weeks of gestation. Gestational age at de-
livery was calculated in days by subtracting the first day
of last menstrual period (LMP) from the date of admis-
sion to delivery room/operation theatre. Confirmation of
gestational age using ultrasound scan was not done since
only limited women had access to this examination. Nine
women with gestational duration > 46 weeks (probably due
to inaccuracy of gestational age calculation), were excluded.
After birth, birth weight and placental dimensions
(weight, length, and width) were measured using a stan-
dardized method by midwives. The placenta-to-birth
weight ratio was calculated [28, 31]. After discharge
from hospital, active follow-up was terminated. Analyses
on neonatal outcomes were based on singleton live birth
pregnancies, and therefore multiple pregnancies, still-
births and miscarriages were excluded from analysis.
Confounding variables
Analyses of the associations between hyperemesis and
placental dysfunction disorders were adjusted for socio-
economic status (family income), second-hand smoking
exposure, maternal age at delivery, gravidity, and pre-
pregnancy body mass index (BMI).
Data analysis
Baseline analysis was stratified by hyperemesis diagnosis
(severe/mild/no hyperemesis), and differences between
groups evaluated with Chi-square, one-way-ANOVA or
Kruskal-Wallis tests where appropriate. For skewed data,
we reported median and interquartile range (IQR). Main
results were expressed as crude and adjusted linear
regression coefficients and odds ratios from logistic
regression, with corresponding 95% confidence intervals
and p-values in tables. All statistical analyses were run
using IBM SPSS (version 22 for Mac).
Fig. 1 Flowchart of subject selection
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Table 1 Baseline characteristics of pregnant women participating in our cohort by HG exposure status
HG exposure P
No HG (n = 1833) Mild HG (n = 354) Severe HG (n = 46)
Demographic characteristics
Age (years) Median (IQR) 28.09 (8.7) 28.13 (7.4) 28.36 (9.1) 0.62
Women’s educationa 0.15
Low 413 (22.6) 73 (20.6) 10 (22.2)
Intermediate 1123 (61.4) 208 (58.8) 31 (68.9)
High 292 (16.0) 73 (20.6) 4 (8.9)
Partner’s educationa 0.23
Low 323 (17.7) 46 (13.0) 9 (20.0)
Intermediate 1199 (65.6) 241 (68.1) 30 (66.7)
High 305 (16.7) 67 (18.9) 6 (13.3)
Family incomeb 0.01*
< 72 USD 197 (10.8) 26 (7.3) 5 (10.9)
72–180 USD 799 (43.6) 169 (47.7) 18 (39.1)
180–360 USD 529 (28.9) 126 (35.6) 16 (34.8)
> 360 USD 124 (6.8) 17 (4.8) 3 (6.5)
Refused to answer 182 (9.9) 16 (4.5) 4 (8.7)
Health characteristics
Pre-pregnancy BMI Median (IQR) 22.0 (5.5) 22.2 (5.5) 23.2 (6.6) 0.59
Chronic hypertension 27 (1.5) 5 (1.4) 0 0.71
Type 2 diabetes 11 (0.6) 2 (0.6) 0 0.87
Partner’s smoking status 0.12
Smokes daily 394 (48.6) 70 (50.7) 8 (36.4)
Smokes occasionally 113 (13.9) 12 (8.7) 1 (4.5)
Doesn’t smoke 304 (37.5) 56 (40.6) 13 (59.1)
Obstetrics characteristics
Primigravida 480 (38.0) 112 (41.5) 12 (34.3) 0.50
Gestational age (weeks) at first visit Median (IQR) 16 (20) 9 (4.50) 10 (5.0) 0.00*
Reported complications in previous pregnancy
No 1070 (84.6) 233 (86.0) 29 (82.9) 0.80
IUGR/SGA 3 (0.2) 0 0 0.70
Hypertensive disorder in pregnancy 44 (2.4) 11 (3.1) 1 (2.2) 0.74
Miscarriage 136 (7.4) 28 (7.9) 2 (4.3) 0.69
Female baby 651 (46) 133 (46.5) 22 (59.5) 0.27
Multiple pregnancy 27 (1.9) 1 (0.4) 0 0.12
Mode of delivery 0.08
Vaginal 871 (61.3) 168 (58.9) 24 (64.9)
Instrumental 33 (3.1) 11 (3.9) 4 (10.8)
Caesarean section 506 (35.6) 106 (37.2) 9 (24.3)
Abbreviations: HG Hyperemesis gravidarum, USD United States Dollar, IUGR intra uterine growth restriction, SGA small for gestational age, IQR inter-quartile range.
Results are median (inter-quartile range) or numbers (percentage); For continuous outcome variables Kruskall-Wallis test was used, for categorical variables, Pearson’s
chi-square test
aLow education = no education, elementary school, junior high school; Intermediate education = senior high school or above; High education = university
bMean monthly total family income, estimated by the patient
*P <0,05
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Results
Study population
Of 2252 participants, 400 were diagnosed with hyperem-
esis gravidarum (18.9%). Of the diagnosed, 94 experi-
enced weight loss varying from 1 to 13 kg. There were
1833 women without, 354 with mild and 46 women with
severe hyperemesis (weight loss > 5%). Subject selection
is shown in Fig. 1. The mean age of participants was
28.3 years, 27% were primigravida.
Table 1 shows the baseline characteristics. The
estimated total family income was used as a proxy of
socio-economic status of the women and was catego-
rized into 4 categories according to its distribution.
We found that family income categories differed
statistically significantly across women from different
exposure groups. Women with hyperemesis also
attended the first ANC visit earlier in gestation than
women without hyperemesis.
Hyperemesis gravidarum (HG) exposure and outcomes
Tables 2, 3 and 4 show associations between hyperem-
esis and placental dysfunction disorders, neonatal
outcomes and placental measures. Mild and severe
hyperemesis were not associated with placental dysfunc-
tion disorders. After adjustment, babies of women with
severe hyperemesis were on average 172 g lighter at
birth than unexposed babies. No associations were found
for SGA and LBW offspring, or other adverse neonatal
outcomes. Women with mild hyperemesis had slightly
lighter placentas while women with severe hyperemesis
had heavier placentas, although none were statistically
significant. Likewise, placental-weight-to-birth weight
ratios (PW/BW ratio) were lower with mild hyperemesis
and higher with severe hyperemesis, although not statis-
tically significant.
Additional analyses regarding the effect of absolute
and relative weight change during the early part of preg-
nancy were also conducted within women with hyper-
emesis gravidarum. However, no associations were
found between early pregnancy weight change with
later placental dysfunction disorders and neonatal or
placental outcomes.
Discussion
This study shows that severe hyperemesis gravidarum is
associated with a significant decrease in birth weight,
but no associations between HG and gestational hyper-
tension, preeclampsia or other placental dysfunction
disorders were observed. No links were found between
hyperemesis gravidarum and neonatal outcomes, such as
SGA and LBW.
Strengths of this study comprise the prospective
design and the number of included women. This allowed
for assessing both first and second trimester effects of
hyperemesis gravidarum on neonatal outcomes and par-
ticularly birth weight, to give an impression of effects on
the placenta, and evaluate early pregnancy weight
change as a possible mediator of the effects. However,
given the low incidence of placental dysfunction disor-
ders, our study may have been too small for definite
inference. Of participants, 18.9% had some form of
hyperemesis, which is very high, but our estimates of
severe hyperemesis do fit previous reports. Notably,
women were recruited from a referral institute for
mother and child health, and indeed some with hyper-
emesis were referred earlier in pregnancy. Although the
data about indication for referral was not available, we
believe that specific referrals for hyperemesis, particu-
larly those in early pregnancy, were for that complaint
only, and not for some associated expectation of higher
risk for adverse maternal or neonatal outcome, such that
selection bias is unlikely. This was supported by our
finding that hyperemetic pregnant women have compar-
able risks for obstetric complications as compared to
women without hyperemesis, which include pre-pregnancy
BMI, chronic hypertension and type 2 diabetes, and previ-
ous obstetric complications. Missing information increased
with longer follow-up, but was largely due to women who
were temporarily provided antenatal care services and
then referred back to primary care, a routine that we
consider unrelated to the association of interest. Our
self-report questionnaire information may contain
Table 2 Hyperemesis gravidarum severity groups and placental
dysfunction disorders
n (%) Crude model Adjusted modela
OR (95% CI) p OR (95% CI) p
Gestational Hypertension
No HG 242 (17.7) Reference Reference
Mild HG 39 (14.5) 0.79 (0.55; 1.13) 0.20 0.87 (0.58; 1.31) 0.51
Severe HG 4 (10.8) 0.56 (0.20; 1.60) 0.28 0.64 (0.22; 1.87) 0.41
Preeclampsia
No HG 77 (6.0) Reference Reference
Mild HG 15 (5.8) 0.97 (0.55; 1.72) 0.92 0.91 (0.47; 1.76) 0.78
Severe HG 2 (5.4) 0.90 (0.21; 3.81) 0.89 0.99 (0.23; 4.34) 0.99
Miscarriage
No HG 136 (7.4) Reference Reference
Mild HG 28 (7.9) 1.07 (0.70; 1.64) 0.75 1.17 (0.60; 2.70) 0.64
Severe HG 2 (4.3) 0.57 (0.13; 2.37) 0.44 - -
Stillbirth
No HG 12 (0.8) Reference Reference
Mild HG 3 (1.0) 1.24 (0.35; 4.43) 0.74 1.41 (0.37; 5.40) 0.62
Severe HG 1 (2.7) 3.26 (0.41; 25.72) 0.26 4.18 (0.50; 35.10) 0.19
Abbreviations: HG hyperemesis gravidarum, OR odds ratio
aAdjusted model: adjusted for socio-economic status (as reflected by income),
smoking status, gravidity, maternal age and pre-pregnancy BMI
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measurement error, but as patients were unaware of
the study aim, such error was likely random.
Our results do not show that severe hyperemesis grav-
idarum increases the risk of placental dysfunction disor-
ders. A link between hyperemesis gravidarum and
placental dysfunction disorders was first suggested in a
1991 case-control study reporting a 1.6 times higher risk
for preeclampsia in women with severe vomiting [43].
Consistent with our findings, previous studies also
showed no increased risks of placenta dysfunction
Table 3 Hyperemesis gravidarum severity groups and neonatal outcome
Values Crude model Adjusted modela
Coefficients (95% CI)b p Coefficients (95% CI)b p
Birthweight (g)c,d
No HG 3100 (476.6) Reference Reference
Mild HG 3116 (464.4) 16.36 (-44.82; 77.54) 0.60 -4.17 (-68.36; 60.02) 0.90
Severe HG 3046 (485.7) -53.86 (-211.15; 103.43) 0.50 -171.72 (-333.26; -10.18) 0.04
SGAc
No HG 212 (16.6) Reference Reference
Mild HG 54 (19.8) 1.24 (0.89; 1.73) 0.20 1.29 (0.87; 1.91) 0.20
Severe HG 6 (17.6) 1.08 (0.44; 2.64) 0.87 1.74 (0.68; 4.44) 0.25
LBWc
No HG 101 (7.4) Reference Reference
Mild HG 21 (7.5) 1.03 (0.63; 1.67) 0.92 1.36 (0.74; 2.51) 0.32
Severe HG 2 (5.6) 0.74 (0.18; 3.13) 0.68 1.44 (0.33; 6.33) 0.63
Gestational age at delivery (in days)e
No HG 274 (17) Reference Reference
Mild HG 275 (13) 0.27 (-2.22; 2.75) 0.83 -0.03 (-2.60; 2.54) 0.98
Severe HG 276 (19) 0.48 (-5.99; 6.96) 0.88 -2.20 (-8.81; 4.42) 0.52
Apgar scorec,e
No HG 9 (0) Reference Reference
Mild HG 9 (0) -0.06 (-0.17; 0.04) 0.24 -0.08 (-0.19; 0.03) 0.15
Severe HG 9 (0) -0.06 (-0.35; 0.23) 0.67 -0.09 (-0.39; 0.21) 0.56
Abbreviations: CI confidence interval, HG hyperemesis gravidarum, g grams, LBW low birthweight, SGA small for gestational age
aAdjusted model: adjusted for socio-economic status (as reflected by income), smoking status, gravidity, maternal age and pre-pregnancy BMI
bResults are expressed as linear regression coefficients (95% CI) in continuous outcomes or OR (95% CI) from logistic regression in case of dichotomous outcomes
cMultiple pregnancies, stillbirths and miscarriages were excluded from the analyses
dValues are reported as mean and standard deviation (SD)
eValues are reported as median and inter-quartile range (IQR)
Table 4 Hyperemesis gravidarum severity groups and placental measures
Values (SD) Crude model Adjusted modela
Coefficients (95% CI)b p Coefficients (95% CI)b p
Placental weight (g)c
No HG 536 (145.2) Reference Reference
Mild HG 530 (102.3) -5.98 (-42.92; 30.95) 0.75 -6.05 (-41.25; 29.15) 0.74
Severe HG 547 (98.4) 10.73 (-126.91; 148.38) 0.88 47.76 (-97.62; 193.14) 0.52
PW/BW ratioc
No HG 0.18 (0.05) Reference Reference
Mild HG 0.18 (0.05) 0.001 (-0.01; 0.01) 0.89 0.002 (-0.01; 0.02) 0.72
Severe HG 0.19 (0.05) 0.02 (-0.03; 0.06) 0.54 0.04 (-0.01; 0.09) 0.15
Abbreviations: CI confidence interval, HG hyperemesis gravidarum, PW/BW ratio placenta-to-birthweight ratio, g grams
aAdjusted model: adjusted for socio-economic status (as reflected by income), smoking status, gravidity, maternal age and pre-pregnancy BMI
bResults are expressed as linear regression coefficients (95% CI)
cMultiple pregnancies, stillbirths and miscarriages were excluded from the analyses
Koudijs et al. BMC Pregnancy and Childbirth  (2016) 16:374 Page 6 of 9
disorders with exposure to hyperemesis [44, 45]. The lar-
gest cohort to date with 1,155,033 pregnancies, of which
13,287 were complicated by hyperemesis leading to hos-
pital admission, showed a slightly increased risk for pre-
eclampsia, and a higher risk for pre-term preeclampsia
when hyperemesis occurred in the second trimester [15].
It has been suggested that differences in outcome in
hyperemetic pregnancies are explained by maternal char-
acteristics such as (gestational) hypertension, (gesta-
tional) diabetes, and primiparity [46]. A general problem
in comparing findings on relations between hyperemesis
and placental dysfunction disorders is the lack of a
widely accepted definition of ‘severe’ hyperemesis.
Working criteria range from hyperemesis requiring
hospitalization or vomiting with associated metabolic
disturbances to classifications purely based on caregiver’s
diagnosis. In this study, the presence of (maternal)
weight loss of more than 5% (compared to the weight
prior to diagnosis) was used as criterion to classify sever-
ity of hyperemesis. The measured relative weight loss
provided a more objective cut off for hyperemesis sever-
ity which is also generalizable to all pregnant women of
different weight.
We showed a (adjusted) 172 g lower birth weight in
offspring of women with severe hyperemesis, which was
not explained by gestational duration. This was in ac-
cordance with several previous reports [22, 46–49]. In
this study, we did not find any association between
hyperemesis and SGA or LBW, although these appeared
more common in women with severe hyperemesis. Al-
though exposed babies were born smaller, it appeared
that their chances of passing the threshold of the 10th
percentile for the gestational age (SGA) or 2500 g for
birth weight (LBW) were equal to the non-exposed. This
agrees with several previous reports, including the
largest study on neonatal outcome to date [21, 27, 50].
Differences in exposure definition and classification of
its severity may contribute to the variation of findings.
Previous research on the association between hyper-
emesis and placental measures is limited. In the present
study, we detected no effects on placental weight and
placenta-weight-to-birth weight ratio (PW/BW ratio).
Women with severe hyperemesis, however, had heavier
placentas and higher of PW/BW ratio, although not sta-
tistically significant. Heavier placentas and higher PW/
BW ratio were previously reported, but only for female
offspring [28]. Studies on famine and placental weight
and PW/BW ratio suggest that with low caloric intake,
the placenta compensatorily grows, probably to maintain
adequate fetal nutrition [31, 32]. This might also occur
with hyperemesis and, therefore, further research on the
placenta is warranted; especially since there is evidence
that compensatory growth of the placenta is associated
with cardiovascular problems in later life [28, 51].
Further research requires clear HG definition and
severity criteria. Large cohort studies will be needed to
estimate relations between hyperemesis and placental
dimensions, and rare outcomes, such as eclampsia and
stillbirth. Conducting follow up studies of women with
severe hyperemesis gravidarum will give a better insight
in possible long term effects of hyperemesis on the
health of children born out of hyperemetic pregnancies.
Conclusions
Hyperemesis gravidarum is an invalidating disease in
early pregnancy, associated with hospitalizations, use of
medication and a poorer quality of life. However, our
findings do indicate no relevant impact of hyperemesis
gravidarum on placental dysfunction disorders.
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